← Evidence map

ArticlePloS one2020

Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice.

Florence Njau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31935212